Kumssa Tsegaye H, Mulu Andargachew, Mihret Adane, Asfaw Zeytu G
Department of Statistics, Hawassa University, Hawassa, Ethiopia.
Armauer Hansen Research Institute (AHRI), Addis Ababa, Ethiopia.
BMC Infect Dis. 2024 Dec 18;24(1):1412. doi: 10.1186/s12879-024-10280-9.
Tuberculosis (TB) remains the most common opportunistic infection and leading cause of death among individuals living with HIV/AIDS in Ethiopia. Its significant impact on morbidity and mortality underscores the crucial link between these two diseases. While the advent of antiretroviral therapy (ART) has led to a dramatic decline in mortality rates among HIV/AIDS patients, TB continues to pose a substantial threat. This study aims to estimate the probability of death due to TB among HIV/AIDS patients on ART, considering the presence of various competing risks, including diarrhea, other infections, and unknown/unspecified causes. Also we have assessed the effects of prognostic factors on HIV/AIDS cause specific deaths, compared with the death from other competing risks, and exploring leading cause of death among HIV/AIDS patients on Antiretroviral Therapy.
Data from a retrospective research examining the effectiveness of antiretroviral therapy (ART) in Ethiopia were used in this investigation. The data came from medical records of patients who were part of the national ART program. A total of 39,590 records were gathered between October 2019 and March 2020 from all regions of Ethiopia as well as the administration cities of Addis Ababa and Dire Dawa. The study facilities were grouped using a multi-stage sample technique and simple random selection was used to select health facility and a person record from medical records. In the presence of the competing causes of death, Cause specific hazard, subdistribution hazard model and flexible parametric proportional hazard model have been used to assess the effect of covariates on the risk of death, with the cmprisk package in R4.3.2 software.
Out of the total 1212 deaths, 542(44.7%) died competing with other opportunistic infection (TE-Esophageal Candidiasis, TO-oral, CT-CNS Toxoplasmosis, CM-Crypotococcal Meningitis…), 421 (34.7%) died due to tuberculosis and the remaining death were unknown/Not specified infection 222(18.3%) and diarrhea 27(2.2%). Rates of mortality caused by tuberculosis, competing with other opportunistic infection, diarrhea and unknown/Not specified were 3.5, 4.5, 0.2 and 1.8 per 1000 person-months, respectively. Having a higher CD4 count at diagnosis, responding to combination antiretroviral treatment (cART) six months after start, and having prophylactic treatment for pneumocystis pneumonia (PCP) decreased the risk of tuberculosis, other opportunistic infections, and unidentified and diarrheal causes of death. However, older age, late HIV.AIDS diagnosis, and the last HIV/AIDS WHO clinical stages increased the hazard of tuberculosis and other opportunistic disease mortality. Additionally, male gender, older age and last HIV clinical stages increased the mortality HIV/AIDS patients.
The findings of this study demonstrated that TB, an opportunistic infection, was the primary cause of death in HIV/AIDS patients, despite the presence of several competing risks, such as diarrhea, other infections, and an undetermined or unclear cause. It's important to use effective techniques to quickly detect those who have HIV or AIDS and provide them with care and treatment to increase their chances of surviving.
在埃塞俄比亚,结核病(TB)仍然是艾滋病毒/艾滋病感染者中最常见的机会性感染和主要死因。它对发病率和死亡率的重大影响突出了这两种疾病之间的关键联系。虽然抗逆转录病毒疗法(ART)的出现使艾滋病毒/艾滋病患者的死亡率大幅下降,但结核病仍然构成重大威胁。本研究旨在估计接受抗逆转录病毒治疗的艾滋病毒/艾滋病患者因结核病死亡的概率,同时考虑各种竞争风险的存在,包括腹泻、其他感染以及不明/未指明原因。此外,我们评估了预后因素对艾滋病毒/艾滋病特定病因死亡的影响,并与其他竞争风险导致的死亡进行比较,同时探索接受抗逆转录病毒治疗的艾滋病毒/艾滋病患者的主要死因。
本研究使用了一项回顾性研究的数据,该研究考察了埃塞俄比亚抗逆转录病毒疗法(ART)的有效性。数据来自参与国家抗逆转录病毒治疗项目患者的医疗记录。2019年10月至2020年3月期间,从埃塞俄比亚所有地区以及亚的斯亚贝巴和德雷达瓦行政城市共收集了39590份记录。研究机构采用多阶段抽样技术进行分组,并使用简单随机抽样从医疗记录中选择医疗机构和个人记录。在存在竞争死因的情况下,使用特定病因风险、亚分布风险模型和灵活参数比例风险模型,借助R4.3.2软件中的cmprisk包来评估协变量对死亡风险的影响。
在总共1212例死亡病例中,542例(44.7%)死于与其他机会性感染竞争(TE - 食管念珠菌病、TO - 口腔、CT - 中枢神经系统弓形虫病、CM - 隐球菌性脑膜炎……),421例(34.7%)死于结核病,其余死亡原因不明/未指明感染222例(18.3%),腹泻27例(2.2%)。结核病、与其他机会性感染竞争、腹泻以及不明/未指明原因导致的死亡率分别为每1000人月3.5例、4.5例、0.2例和1.8例。诊断时CD4细胞计数较高、开始联合抗逆转录病毒治疗(cART)六个月后有反应以及接受肺孢子菌肺炎(PCP)预防性治疗可降低结核病、其他机会性感染以及不明和腹泻性死因的风险。然而,年龄较大、艾滋病毒/艾滋病诊断较晚以及世界卫生组织艾滋病毒/艾滋病最后临床阶段增加了结核病和其他机会性疾病死亡的风险。此外,男性、年龄较大以及艾滋病毒最后临床阶段增加了艾滋病毒/艾滋病患者的死亡率。
本研究结果表明,尽管存在腹泻、其他感染以及未确定或不明确原因等多种竞争风险,但机会性感染结核病仍是艾滋病毒/艾滋病患者的主要死因。使用有效技术快速检测出艾滋病毒或艾滋病感染者并为其提供护理和治疗以增加他们的存活机会非常重要。